¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

ÇѽŰæ¸é¿ªÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ : 2024-08-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

ÇѽŰæ¸é¿ªÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ : 2024-08-17
±³À°ÀÏÀÚ : 2024-08-17
±³À°Àå¼Ò : ¼­¿ï º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ë (¿ÀÇÁ¶óÀÎ °³ÃÖ)

±³À°ÁÖÁ¦ : ´ëÇѽŰæ¸é¿ªÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ¸é¿ªÇÐȸ

´ã´çÀÚ : ´ëÇѽŰæ¸é¿ªÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-720-1594

À̸ÞÀÏ : ksms1594@naver.com

±³À°Á¾·ù : ½Å°æ°ú

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 90,000¿ø  

ºñ°í »çÀüµî·Ï: Àü°øÀÇ ¹«·á, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø / ´çÀϵî·Ï: Àü°øÀÇ ¹«·á, Àü¹®ÀÇ,±âŸ(ȸ¿ø) 5¸¸¿ø, ºñȸ¿ø 9¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 09:30~09:55 Updates in NMOSD and MOGAD ±è±âÈÆ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 09:55~10:20 Updates in multiple sclerosis ÀÌÇý¸²(°í·ÁÀÇ´ë)

Åä·Ð 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 10:20~10:30 Q&A ¼¼¼Ç¿¬ÀÚ ¸ðµÎ()

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 10:40~11:00 Radiologically Isolated Syndrome and MS prodrome ±èÁöÀº(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 11:00~11:20 Intergrating serum neurofilament light chain into clinical practice: The next frontiers in MS disease activity and prognosis assessment ±è¼öÇö(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 11:20~11:40 Emerging Cell Therapies in mutiple sclerosis ¼®Áø¸í(¼øõÇâÀÇ´ë)

Åä·Ð 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 11:40~11:50 Q&A ¼¼¼Ç¿¬ÀÚ ¸ðµÎ()

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 11:50~12:30 Invited lecture : Microbiome in Neurodegenerative Disease ¹¬ÀÎÈñ(¼­¿ï´ëÇб³)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 13:00~13:30 Scientific session ¥°(Neuroimmunology & Multiple Sclerosis (MS)) ¹ÎÁÖÈ«(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 13:30~14:00 Special Session: Sharing experience for networking and research ½ÅÇÏ¿µ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 14:00~15:00 Scientific session ¥± (Neuroimmunology & Multiple Sclerosis (MS)) ¿ÀÁö¿µ, ±èº´Á¶(°Ç±¹ÀÇ´ë, °í·ÁÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 15:15~15:35 Role of B cell in Multiple sclerosis ±èÇöÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 15:35~15:55 B cell depletion treatments for multiple sclerosis: Real-world data ±Ç¿µ³²(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 15:55~16:15 Bruton tyrosine kinase inhibitors for multiple sclerosis ±Ç¼ø¿í(ÀÎÇÏÀÇ´ë)

Åä·Ð 08¿ù 17ÀÏ º¸ÄÚ¼­¿ï°­³² LLÃþ(B2) º¼·ëȦ 16:15~16:25 Q&A ¼¼¼Ç¿¬ÀÚ ¸ðµÎ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÇѽŰæ¸é¿ªÇÐȸ 2024³â ÇÏ°èÇмú´ëȸ : 2024-08-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Rhinology update symposium in 2024 : 2024-08-18
´ÙÀ½±Û ´ëÇÑÀÓ»óÃÊÀ½ÆÄÇÐȸ Á¦24ȸ Ãá°èÇмú´ëȸ : 2024-08-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21182 °æ±â Á¦6ȸ °¡Å縯´ëÇб³ ¼ººó¼¾Æ®º´¿ø ¾Ï ½ÉÆ÷Áö¾ö(¿ÀÇÁ¶óÀÎ/¿Â¶óÀÎ) : 2024-07-26 0 20 2024-07-02
21181 ´ë±¸ Çѱ¹¿©ÀÚÀÇ»çȸ ´ë±¸°æºÏÁöȸ 7¿ù Çмú½ÉÆ÷Áö¾ö(ºÒ¸éÁõ, ¼ö¸éÁ¦, Ȳ¹Ýº¯¼º ¹× ³ëÈ­ °ü·Ã ¾ÈÁúȯ) : 2024-07-23 0 25 2024-07-02
21180 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø (¿Â¶óÀÎ) Á¦12ȸ ¼­¿ï ÀÓ»ó¾îÁö·³Áõ ¼¼¹Ì³ª : 2024-07-21 0 32 2024-07-02
21179 ¼­¿ï ¼Ò¾Æû¼Ò³âÇൿ¹ß´ÞÁõÁø ÇнÀÀå¾Ö ÇÁ·Î±×·¥ ¿öÅ©¼ó : 2024-07-21 0 40 2024-07-02
21178 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°ú½ºÆ÷Ã÷ÀÇÇÐȸ - Á¦2Â÷ ½ºÆ÷Ã÷ ¼Õ»ó ½ÉÆ÷Áö¾ö : 2024-07-21 0 23 2024-07-02
21177 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (2ÀÏÂ÷) : 2024-07-20 0 14 2024-07-02
21176 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦2ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-07-20 0 13 2024-07-02
21175 ¼­¿ï 21st Head and Neck Workshop (»ï¼º¼­¿ïº´¿ø & ´ëÇѵΰæºÎ¿Ü°úÇÐȸ) : 2024-07-20 0 18 2024-07-02
21174 ¼­¿ï 2024 ´ëÇÑÈ£Èí°ü¸®ÇÐȸ Á¦32Â÷ Çмú´ëȸ : 2024-07-20 0 20 2024-07-02
21173 ¼­¿ï 2024³â ´ëÇÑ°íÇ÷¾ÐÇÐȸ ´ë»çÁõÈıº¿¬±¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-07-20 0 15 2024-07-02
21172 ¼­¿ï Á¦4ȸ ´ëÇѼÒÈ­±âÇÐȸ °æ±âÀÎõÁöȸ ½ÉÆ÷Áö¾ö ¹× ¿¬±¸°úÁ¦ ¹ßǥȸ : 2024-07-20 0 16 2024-07-02
21171 ¼¼Á¾ 2024³â ´ëÇÑ°í°üÀýÇÐȸ °üÀýº¸Á¸ ½ÉÆ÷Áö¿ò : 2024-07-20 0 27 2024-07-02
21170 ¿ï»ê 2024³â Á¦7ȸ ´ëÇÑÇ׳ëÈ­ºñ´¢ÅëÇÕ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-20 0 26 2024-07-02
21169 ¼­¿ï PH Korea 2024 with 4th EASOPH(Á¦9ȸ Æó°íÇ÷¾Ð Çмú´ëȸ) (1ÀÏÂ÷) : 2024-07-19 0 26 2024-07-02
21168 ¼­¿ï ´ëÇÑ»çȸÁ¤½ÅÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-19 0 36 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷